Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease

Paricalcitol, a selective vitamin D receptor (VDR) activator used for treatment of secondary hyperparathyroidism in chronic kidney disease (CKD), has been associated with survival advantages, suggesting that this drug, beyond its ability to suppress parathyroid hormone, may have additional beneficia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Donate-Correa, J., Domínguez-Pimentel, V., Méndez-Pérez, M. L., Muros-de-Fuentes, M., Mora-Fernández, C., Martín-Núñez, E., Cazaña-Pérez, V., Navarro-González, J. F.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913352/
https://ncbi.nlm.nih.gov/pubmed/24511210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/670475
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados